We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
Cap. Flow
-$105M
Cap. Flow %
-7.96%
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229

Top Buys

Rank Stock Value
1
ALLK
Allakos
ALLK
+$7.87M
2
PATH icon
UiPath
PATH
+$6.99M
3
MQ icon
Marqeta
MQ
+$6.41M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.72M
5
FIGS icon
FIGS
FIGS
+$5.31M

Top Sells

Rank Stock Value
1
MDB icon
MongoDB
MDB
+$7M
2
CRL icon
Charles River Laboratories
CRL
+$6.37M
3
FND icon
Floor & Decor
FND
+$5.83M
4
BRKR icon
Bruker
BRKR
+$5.34M
5
ASAN icon
Asana
ASAN
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 24.86%
2 Healthcare 21.49%
3 Industrials 12.78%
4 Consumer Discretionary 11.8%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTG icon
876
B2Gold
BTG
$5.12B
– –
-53,300
Closed -$182K
BTU icon
877
Peabody Energy
BTU
$2.83B
– –
-16,300
Closed -$241K
CABA icon
878
Cabaletta Bio
CABA
$445M
– –
-10,956
Closed -$133K
CC icon
879
Chemours
CC
$2.57B
– –
-29,034
Closed -$844K
CCEP icon
880
Coca-Cola Europacific Partners
CCEP
$49.2B
– –
-9,800
Closed -$542K
CENTA icon
881
Central Garden & Pet Co Class A
CENTA
$2.44B
– –
-7,255
Closed -$250K
CGC
882
Canopy Growth
CGC
$377M
– –
-21,430
Closed -$2.97M
CGNX icon
883
Cognex
CGNX
$10B
– –
-54,200
Closed -$4.35M
CHGG icon
884
Chegg
CHGG
$121M
– –
-14,414
Closed -$980K
CHRD icon
885
Chord Energy
CHRD
$7.25B
– –
-5,750
Closed -$572K
CIEN icon
886
Ciena
CIEN
$49.6B
– –
-7,200
Closed -$370K
CIVI
887
DELISTED
Civitas Resources
CIVI
– –
-12,017
Closed -$576K
CLAR icon
888
Clarus
CLAR
$128M
– –
-20,300
Closed -$520K
CMTL icon
889
Comtech Telecommunications
CMTL
$51.5M
– –
-21,372
Closed -$547K
CNX icon
890
CNX Resources
CNX
$4.84B
– –
-87,077
Closed -$1.1M
CODX
891
Co-Diagnostics
CODX
$5.2M
– –
-689
Closed -$201K
CRS icon
892
Carpenter Technology
CRS
$27.8B
– –
-9,254
Closed -$303K
CRSP icon
893
CRISPR Therapeutics
CRSP
$4.68B
– –
-7,906
Closed -$885K
CSTL icon
894
Castle Biosciences
CSTL
$725M
– –
-5,351
Closed -$356K
CVGW
895
DELISTED
Calavo Growers
CVGW
– –
-17,474
Closed -$668K
CYCN icon
896
Cyclerion Therapeutics
CYCN
$15.2M
– –
-1,505
Closed -$92K
CYRX icon
897
CryoPort
CYRX
$765M
– –
-6,600
Closed -$439K
DB icon
898
Deutsche Bank
DB
$67.6B
– –
-56,114
Closed -$717K
DECK icon
899
Deckers Outdoor
DECK
$14.2B
– –
-14,400
Closed -$864K
DENN
900
DELISTED
Denny's
DENN
– –
-89,300
Closed -$1.46M
34 35
36
37 38

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PDT Partners's Q4 2021 Portfolio in Review

As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, PDT Partners opened a new position in Allakos worth $940K.

  • PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
  • PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
  • PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
  • PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
  • PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
  • PDT Partners opened 330 new positions and closed 229 in Q4 2021.
  • PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.